Latest Breaking News On - Shavit capital - Page 3 : comparemela.com

MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio

MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio
newsmakers.pk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsmakers.pk Daily Mail and Mail on Sunday newspapers.

United statesPatrick zhangKfir emmerUs department of defenseCaesara medical holdingsTechnology investmentEu commissionDrug administrationUnion tech venturesMemed keyHorizons venturesShavit capitalSocial capitalTouchwood capitalClai insurancePhoenix insurance

MeMed Closes $93M Private Financing Round

The company said it will use the funds to scale manufacturing and accelerate commercialization of its MeMed BV and MeMed COVID-19 Severity tests.

United statesPatrick zhangCaesara medical holdingsTechnology investmentDrug administrationUnion tech venturesHorizons venturesShavit capitalSocial capitalTouchwood capitalClai insurancePhoenix insurancePoalim equityWestern technologyHorizon venture

Israeli Med-Tech start-up to begin scale-up after $93 million funding

Israeli Med-Tech start-up to begin scale-up after $93 million funding
jpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jpost.com Daily Mail and Mail on Sunday newspapers.

United statesYogev azrielPatrick zhangUs department of defenseTechnology investmentCaesarea medical holdingsEu commissionDrug administrationUnion tech venturesEran edenHorizons venturesShavit capitalSocial capitalTouchwood capitalClai insurancePhoenix insurance

Israeli diagnostics co MeMed raises $93m

MeMed's technology rapidly distinguishes bacterial and viral infections, and can predict which Covid-19 patients need drug treatment.

United statesIsrael generalPatrick zhangArnon samburskiNaschitz brandes amirMayrav danorCaesara medical holdingsTechnology investmentEu commissionDrug administrationUs department of defenseUnion tech venturesHorizons venturesShavit capitalSocial capitalTouchwood capital

Alpha radiation startup eliminates 70% of cancerous tumors

Now going into clinical trials for specific types of cancer, Alpha Tau’s technology shows potential for treating any solid tumor.

New yorkUnited statesUnited kingdomKaluzhskaya oblastItzhak kelsonAlpha daYona keisariEuropean unionTel aviv universityProfessors yona keisariTel avivUzi soferAlpha tauShavit capitalMedison venturesAlpha emitters radiation